Global Swine Vaccine Market to Reach USD 2.7 Billion by 2032, Growing at a CAGR of 5.8%

The global swine vaccine market, valued at approximately USD 1.5 billion in 2021, is poised for steady growth, according to a newly released market analysis report by Future Market Insights. The market is projected to grow at a Compound Annual Growth Rate (CAGR) of 5.8% from 2022 to 2032, creating an absolute dollar opportunity of USD 1.2 billion during the forecast period. This marks a notable increase over the historical CAGR of 4.9%. The inactivated vaccines segment is expected to lead the market, outpacing other vaccine types with a CAGR of 5.9% from 2022 to 2032. Additionally, Porcine Circovirus Type 2 has emerged as the top revenue-generating segment within the global swine vaccine market. This segment is anticipated to grow at a CAGR of 5.6% over the forecast period, driven by increasing demand for disease prevention in swine populations. The COVID-19 pandemic is predicted to have impacted the business operations of prominent swine vaccine players adversely. Impact of the pand